NovaBay Issues Statement Regarding Market Activity – msnbc.com

EMERYVILLE, Calif., Feb. 29, 2012 (GLOBE NEWSWIRE) — NovaBay ® Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide® compounds for the local non-systemic …